{"id":70699,"date":"2026-05-12T09:19:23","date_gmt":"2026-05-12T09:19:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70699"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"selank","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/selank\/","title":{"rendered":"Selank"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist Selank?<\/h3>\n<p style=\"margin: 0;\"><strong>Selank<\/strong> is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">129954-34-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulargewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">751.88 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH<sub>2<\/sub> (TKPRPGP-NH<sub>2<\/sub>, 7 Aminos\u00e4uren; C-terminal amidiertes Tuftsin-Analogon)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat (wei\u00df bis leicht gelblich)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Reinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-best\u00e4tigt, COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat: 2\u20138 \u00b0C (K\u00fchlschrank) f\u00fcr Arbeitsvorrat; \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituiert: 2\u20138 \u00b0C, innerhalb von ~30 Tagen verwenden. Vor Licht sch\u00fctzen. Die rekonstituierte L\u00f6sung nicht einfrieren und auftauen.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slichkeit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Was ist Selank?<\/h2>\n<p><strong>Selank<\/strong> is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a>. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank&#8217;s well-characterised sequence is TKPRPGP-NH<sub>2<\/sub>, Molekulargewicht 751,88 Da, empirische Formel C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> Produktseite. <\/p>\n<h2>Wirkmechanismus \u2014 GABAerge, serotonerge und BDNF-Signalwege<\/h2>\n<p>What makes Selank distinctive among anxiolytic compounds is its <strong>multimodales neuromodulatorisches Profil<\/strong> ohne direkte Rezeptorbindung an die GABA-<sub>A<\/sub> benzodiazepine site \u2014 each contributing to the observed anxiolytic and nootropic phenotype in published studies:<\/p>\n<ul>\n<li><strong>GABAerge Modulation ohne Bindung an die Benzodiazepin-Stelle<\/strong> \u2014 Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank&#8217;s pharmacology.<\/li>\n<li><strong>Serotonerge und enkephalinerge Signal\u00fcbertragung<\/strong> \u2014 Published studies has documented increased serotonin metabolism (5-HIAA \/ 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.<\/li>\n<li><strong>BDNF-Expression und Neuroplastizit\u00e4t<\/strong> \u2014 Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank&#8217;s nootropic profile \u2014 improved memory consolidation and learning performance in rodent maze tasks.<\/li>\n<\/ul>\n<p>Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Selank is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Anxiolytische Pharmakologie<\/strong> \u2014 Elevated-Plus-Maze-, Open-Field- und soziale Interaktions-Tests in Nagetiermodellen generalisierter Angst; Vergleichsarme gegen Benzodiazepine (Diazepam) und SSRIs (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)<\/li>\n<li><strong>Stress resilience and HPA-axis studies<\/strong> \u2014 chronischer milder Stress, Restraint-Stress und gelernte-Hilflosigkeits-Modelle; Cortisol- und ACTH-Dynamik<\/li>\n<li><strong>BDNF and neuroplasticity studies<\/strong> \u2014 hippocampale und pr\u00e4frontale BDNF-Expression, Dendritendornen-Morphologie, Langzeitpotenzierungselektrophysiologie<\/li>\n<li><strong>Cognitive and memory studies<\/strong> \u2014 Morris-Wasserlabyrinth, neuartige Objekterkennung, passive Vermeidung; nootrope Effekte unabh\u00e4ngig von Anxiolyse<\/li>\n<li><strong>Immunmodulation<\/strong> \u2014 Selank inherits tuftsin&#8217;s immunomodulatory activity, with documented effects on cytokine balance (TNF-\u03b1, IL-6, IFN-\u03b3) and macrophage function in published studies<\/li>\n<li><strong>Comparative studies vs benzodiazepines<\/strong> \u2014 direkter Vergleich mit Diazepam, Alprazolam und Phenazepam hinsichtlich anxiolytischer Wirksamkeit, Abh\u00e4ngigkeitspotenzial und Rebound-Effekten; Selanks sauberes Absetzprofil ist einer der am h\u00e4ufigsten zitierten Befunde in der russischen Literatur<\/li>\n<li><strong>Sister-peptide studies<\/strong> \u2014 Benchmarking gegen <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.<\/li>\n<\/ul>\n<p>For broader context on small-peptide neuromodulation and nootropic studies, see <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> als der kanonische russisch-entwickelte nootrope Vergleichsstoff, <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/de\/bpc-157\/\">BPC-157<\/a> for the parallel small-peptide healing-compound. Browse the full <a href=\"https:\/\/medsbase.com\/de\/peptides\/\">Peptid-Katalog<\/a> f\u00fcr verwandte Verbindungen. <\/p>\n<h2>Verf\u00fcgbare St\u00e4rken und Konzentrationen<\/h2>\n<p>MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vial-St\u00e4rke<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typischer Anwendungsfall<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Packungsgr\u00f6\u00dfen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, intranasal-vehicle formulation studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols. <\/p>\n<h2>Vergleich \u2014 Selank vs Semax<\/h2>\n<p>Selank und <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic\/neuroprotective. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>L\u00e4nge<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 Aminos\u00e4uren (Heptapeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 Aminos\u00e4uren (Heptapeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mutterpeptid<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tuftsin (TKPR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">ACTH(4-10)-Fragment<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e4rer Mechanismus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GABA-Modulation, BDNF, Enkephalin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BDNF, Melanocortin-Rezeptoren, Dopamin<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anxiolytisch, Stressresistenz<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootropikum, neuroprotektiv, Fokus<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 \u00b5g\/Tag<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u20131.000 \u00b5g\/Tag<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Klinische Anwendung in Russland<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Zugelassenes Anxiolytikum (nasal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Zugelassenes Nootropikum\/Schlaganfallrehabilitation (nasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking in studies<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">H\u00e4ufig mit Semax kombiniert f\u00fcr komplement\u00e4re anxiolytische+nootrope Wirkung<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">H\u00e4ufig mit Selank kombiniert<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because the two peptides act on complementary axes \u2014 Selank on GABA\/anxiolytic, Semax on melanocortin\/dopaminergic\/nootropic \u2014 they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype. <\/p>\n<h2>Lagerung und Rekonstitution<\/h2>\n<p><strong>Vor der Rekonstitution:<\/strong> Lyophilisierte Fl\u00e4schchen gek\u00fchlt bei 2\u20138 \u00b0C in Originalverpackung f\u00fcr kurzfristigen Gebrauch lagern. F\u00fcr unge\u00f6ffnete Langzeitlagerung bei \u221220 \u00b0C einfrieren. Lyophilisiertes Selank ist unter K\u00fchlung bis zu 24 Monate und bei \u221220 \u00b0C bis zu 36 Monate stabil. Vermeiden Sie Gefrier-Tau-Zyklen des lyophilisierten Pulvers. <strong>Rekonstitutionsverfahren:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 1.0\u00a0mL of bacteriostatic water yields a 5\u00a0mg\/mL working concentration; 0.1\u00a0mL delivers a 500\u00a0mcg dose. Swirl gently \u2014 do <strong>nicht<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>gek\u00fchlt bei 2\u20138 \u00b0C lagern und innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren.<\/strong> Rekonstituierte L\u00f6sung bei 2\u20138 \u00b0C k\u00fchl lagern und innerhalb von 30 Tagen f\u00fcr optimale Stabilit\u00e4t verwenden. Die rekonstituierte L\u00f6sung nicht einfrieren \u2013 Gefrier-Tau-Zyklen beeintr\u00e4chtigen die Peptidintegrit\u00e4t. Fl\u00e4schchen mit Tr\u00fcbung, Ausf\u00e4llung oder Verf\u00e4rbung verwerfen. <\/p>\n<h2 id=\"faqs\">H\u00e4ufig gestellte Fragen<\/h2>\n<h3>What is Selank used for in studies?<\/h3>\n<p>Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is <strong>nicht<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Wie unterscheidet sich Selank von Semax?<\/h3>\n<p>Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways \u2014 canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation \u2014 canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping. <\/p>\n<h3>What is the typical Selank dose?<\/h3>\n<p>Published Russian protocols typically use 300\u2013900\u00a0mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5\u00a0mg vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 0.1\u00a0mL equals 500\u00a0mcg, a typical single-dose studies aliquot. <\/p>\n<h3>Ist Selank von der FDA zugelassen?<\/h3>\n<p>No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez). <\/p>\n<h3>Wie sollte Selank gelagert werden?<\/h3>\n<p>Lyophilisierte Fl\u00e4schchen: gek\u00fchlt bei 2\u20138 \u00b0C f\u00fcr kurzfristige Arbeitsbest\u00e4nde oder \u221220 \u00b0C f\u00fcr die Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituierte L\u00f6sung: gek\u00fchlt bei 2\u20138 \u00b0C, innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren \u2013 Gefrier-Auftau-Zyklen degradieren das Peptid. Immer vor direktem Licht sch\u00fctzen. <\/p>\n<h3>Wie rekonstituiere ich Selank?<\/h3>\n<p>Befolgen Sie das oben beschriebene Rekonstitutionsverfahren. Geben Sie bakterienstatisches Wasser an der Seitenwand des Fl\u00e4schchens hinzu (nicht auf den lyophilisierten Kuchen), schwenken Sie vorsichtig und lassen Sie 2\u20135 Minuten zur vollst\u00e4ndigen Aufl\u00f6sung. Sch\u00fctteln Sie <strong>nicht<\/strong> Sch\u00fctteln Sie das Fl\u00e4schchen nicht. Eine korrekt rekonstituierte L\u00f6sung ist klar und farblos. Bei einem 5 mg-Fl\u00e4schchen + 1,0 mL Verd\u00fcnnungsmittel betr\u00e4gt die Arbeitskonzentration 5 mg\/mL. <\/p>\n<h3>Welche St\u00e4rken f\u00fchrt MedsBase?<\/h3>\n<p>MedsBase carries Selank in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Selank be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models. <\/p>\n<h3>Can Selank and Semax be stacked in studies?<\/h3>\n<p>Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA\/enkephalin\/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin\/dopaminergic\/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress. <\/p>\n<h3>Does Selank cause side reported effects?<\/h3>\n<p>Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation \u2014 in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review. <\/p>\n<h3>Wie ist die Halbwertszeit von Selank?<\/h3>\n<p>In preclinical studies, Selank has an estimated plasma half-life of approximately 15\u201330 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance. <\/p>\n<h3>How long does Selank take to show effects in preclinical studies?<\/h3>\n<p>Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30\u201360 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7\u201314 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models. <\/p>\n<h3>Kann ich Selank f\u00fcr den internationalen Versand bestellen?<\/h3>\n<p>Ja. MedsBase versendet Selank weltweit \u00fcber unser spezielles Peptid-Versandnetzwerk. Bestellungen ausschlie\u00dflich mit Peptiden qualifizieren sich f\u00fcr unseren eigenst\u00e4ndigen Peptidversandservice. Alle Sendungen werden in temperaturkontrollierter Verpackung mit vollst\u00e4ndiger Sendungsverfolgung versandt und sind durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies<\/h2>\n<ul>\n<li><a href=\"\/de\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Sister heptapeptide from the same Russian clinical \u2014 nootropic and neuroprotective studies<\/li>\n<li><a href=\"\/de\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/de\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<li><a href=\"\/de\/kpv-lysine-proline-valine\/\"><strong>KPV<\/strong><\/a> \u2014 Small immunomodulatory tripeptide \u2014 inflammation and barrier studies<\/li>\n<li><a href=\"\/de\/adamax\/\"><strong>Adamax<\/strong><\/a> \u2014 Heptapeptide nootropic compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Weiterf\u00fchrende Literatur<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore small-peptide nootropic studies<\/strong><\/p>\n<p style=\"margin: 0;\">Durchst\u00f6bern Sie das gesamte Sortiment <a href=\"https:\/\/medsbase.com\/de\/peptides\/\"><strong>Peptid-Katalog<\/strong><\/a>, mit verwandten Verbindungen einschlie\u00dflich <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> for melanocortin-axis nootropic studies, <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/de\/adamax\/\">Adamax<\/a> for sister heptapeptide cognitive studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Anxiolytikum ohne Sedierung<br \/>\n\u2705 Multimodale Modulation von GABA \/ BDNF \/ Enkephalin<br \/>\n\u2705 Stress-resilience compound<br \/>\n\u2705 Intranasal bioverf\u00fcgbares Peptid<br \/>\n\u2705 Sauberes Absetzprofil im Vergleich zu Benzodiazepinen<\/p>\n<p><strong>Selank<\/strong> enth\u00e4lt synthetische Peptidverbindung.<\/p>","protected":false},"featured_media":70977,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,6273],"class_list":["post-70699","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-selank","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/70699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=70699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/70977"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=70699"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=70699"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=70699"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=70699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}